Jazz Pharmaceuticals (JAZZ) Cash from Operations (2010 - 2026)

Jazz Pharmaceuticals' Cash from Operations history runs 17 years deep, the most recent figure standing at 408200000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 5.03% year-over-year to 408200000.0; the TTM figure through Mar 2026 stood at 1334173000.0 (down 14.39% YoY), while the FY2025 annual figure was 1355773000.0, down 2.88% from the prior year.
• Cash from Operations was 408200000.0 for Q1 2026 at Jazz Pharmaceuticals, up from 362518000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 474616000.0 in Q3 2025 to a low of 88839000.0 in Q2 2025.
• Historically, Cash from Operations has averaged 324933235.29 across 5 years, with a median of 331352000.0 in 2024.
• The sharpest annual moves came in 2022 and 2025: Cash from Operations surged 626.79% in 2022, then sank 73.19% in 2025.
• A 5-year view of Cash from Operations shows it stood at 341971000.0 in 2022, then tumbled by 51.07% to 167339000.0 in 2023, then soared by 138.19% to 398580000.0 in 2024, then declined by 9.05% to 362518000.0 in 2025, then advanced by 12.6% to 408200000.0 in 2026.
• The last three Cash from Operations figures came in at 408200000.0 (Q1 2026), 362518000.0 (Q4 2025), and 474616000.0 (Q3 2025), per Business Quant data.